Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction

Published:2016-05 Issue:5 Volume:4 Page:392-402
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

King Jordan B.,Shah Rashmee U.,Bress Adam P.,Nelson Richard E.,Bellows Brandon K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS);N Engl J Med,1987

2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure;N Engl J Med,1991

3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF);Lancet,1999

4. Safety and efficacy of carvedilol in severe heart failure;Cohn;J Card Fail,1997

5. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure;Cohn;N Engl J Med,2001

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin receptor blocker-neprilysin inhibitor for heart failure with reduced ejection fraction;Pharmacological Research;2024-06

2. Cost–Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China;American Journal of Cardiovascular Drugs;2024-04-15

3. Long‐term cost‐effectiveness of transcatheter mitral valve repair in HF patients with secondary mitral regurgitation;ESC Heart Failure;2024-03-22

4. Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes;Journal of Medical Economics;2024-03-11

5. Cost-effectiveness of cardiomyopathy ambulatory care with sacubitril/valsartan vs standard therapy after COVID-19 in Kazakhstan;Pharmacia;2024-02-08